Delivery Order SPE2DB22D2005-SPE2DB25FJLZ5
Award Date 5/6/25
Potential Completion Date 5/28/25
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order for ProQuad vials valued at $6,683.60 by the Defense Logistics Agency (DLA). The contract, awarded on July 21, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,055.26 by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of ProQuad vials. The contract features firm fixed pricing with no set-aside designation, indicating it was competitively awarded. Performance is scheduled for completion by September 23, 2025, at the vendor's Conshohocken facility. This delivery order operates as...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,341.80 by the Defense Logistics Agency on June 18, 2025, for the supply of ProQuad vials. The award is a non-set-aside, firm fixed price delivery order with an ultimate completion date of July 11, 2025. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on June 2, 2025, for ProQuad vials with a ceiling value of $2,740.40. This firm fixed price contract, with an ultimate completion date of June 24, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,437.20 by the Defense Logistics Agency on September 2, 2025, for the supply of ProQuad vials with a completion date of September 23, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office division. The place of performance is AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. This delivery order operates under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,687.48 by the Defense Logistics Agency on September 11, 2025, for the supply of ProQuad vials. This non-competitive, firm fixed-price delivery order is expected to be completed by October 2, 2025, with performance taking place at the vendor's Conshohocken facility. The award represents a child contract issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,341.80 by the Defense Logistics Agency (DLA) for ProQuad vials, a vaccine product. The contract is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance will take place at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 29, 2025, for ProQuad vials with a ceiling value of $50,127. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 22, 2025. The delivery order is being performed at the company's corporate office location in Conshohocken, Pennsylvania. This award falls under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $1,604.66 from the Defense Logistics Agency (DLA) on December 5, 2025, for ProQuad vials with a completion date of December 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's broader federal pharmaceutical supply arrangements. This delivery...
- The Defense Logistics Agency awarded a $3,341.80 delivery order to AmerisourceBergen Drug Corp for ProQuad vials on June 20, 2025, with an ultimate completion date of July 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop...